Trevi Therapeutics Aktie
11,04
USD
-0,27
USD
-2,39
%
11,06
USD
-0,26
USD
-2,25
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung